首页> 外国专利> VIIa factor inhibitors, a preparation process, a drug synthesis, and use it to make a drug that reduces the inflammatory response to blood clotting or cardiovascular disease, thrombopathy, or restorative disorders.

VIIa factor inhibitors, a preparation process, a drug synthesis, and use it to make a drug that reduces the inflammatory response to blood clotting or cardiovascular disease, thrombopathy, or restorative disorders.

机译:VIIa因子抑制剂,制备方法,药物合成,并将其用于制备可减少对凝血或心血管疾病,血栓形成或修复性疾病的炎症反应的药物。

摘要

This refers to compounds of Formula (1) in which R1, R2, R91, R92, R93, R94, R95, R96, R97, r, s and t have the meanings indicated in the claims. The compounds of Formula (1) are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable, for example,For the treatment and prevention of thrombotic or restorative diseases. They are reversible inhibitors, which can be widely used in the inhibition treatment of the inhibition of the VIIa factors in the case of unexpected activities of the VIIa, or in the case of trying to inhibit the VIIa factors. In addition, the process (1) applied to the preparation of deformation compounds,2. Use it as, in particular, active ingredients in pharmaceutical synthesis and pharmaceutical preparations containing these ingredients;
机译:这是指式(1)的化合物,其中R 1,R 2,R 91,R 92,R 93,R 94,R 95,R 96,R 97,r,s和t具有权利要求中所指示的含义。式(1)的化合物是有价值的药理活性化合物。它们具有很强的抗血栓形成作用,适合于例如治疗和预防血栓形成或恢复性疾病。它们是可逆的抑制剂,在VIIa的意外活性的情况下或在试图抑制VIIa因子的情况下,可以广泛用于抑制VIIa因子的抑制治疗。另外,方法(1)适用于变形化合物的制备; 2。特别是将其用作药物合成中的活性成分和含有这些成分的药物制剂;

著录项

  • 公开/公告号AR024292A1

    专利类型

  • 公开/公告日2002-09-25

    原文格式PDF

  • 申请/专利权人 SANOFI-AVENTIS DEUTSCHLAND GMBH;

    申请/专利号AR2000P102796

  • 发明设计人

    申请日2000-06-06

  • 分类号C07K5/06;A61K38/05;A61P7/02;

  • 国家 AR

  • 入库时间 2022-08-22 00:46:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号